- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00279097
Safety Study to Evaluate Intracranial Pressure During High Frequency Chest Wall Oscillation
November 15, 2006 updated by: Hill-Rom
A Safety Study to Evaluate Intracranial Pressure With the Utilization of High Frequency Chest Wall Oscillation (HFCWO) Using the Vest™ on Mechanically Ventilated Neurosurgical Patients
The purpose of this study is to evaluate changes in intracranial pressure (ICP) during or immediately following high frequency chest wall oscillation (HFCWO) treatment with the Vest™ in neurosurgical subjects.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
This study is a single site safety study to evaluate changes in intracranial pressure during or immediately following HFCWO treatment with the Vest™ in neurosurgical subjects with intracranial pressure monitors having normal opening pressures and ICP less than or equal to 20 mmHg.
The secondary objective of this study is to evaluate changes in arterial blood gases that may result with Vest™ therapy in ventilated patients.
Study Type
Interventional
Enrollment
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- University of Texas at Houston/Memorial Hermann Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ICP monitor with normal opening pressure (greater than or equal to 20 mmHg)
- On ventilator
- Arterial line in place
- Age equal to or greater than 18
- Admitted to neurotrauma intensive care unit (ICU)
Exclusion Criteria:
- Inability to obtain informed consent
- Unstable spinal cord injury
- ICP > 20 mmHg sustained for > 5 minutes
- Hemodynamic instability within the prior 12 hours
- Active hemoptysis
- Hemothorax
- New onset, unstable arrhythmia
- Enrollment in another interventional study
- Aneurysm that has not been clipped or coiled
- Coagulopathic head injury subjects
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Intracranial pressure
|
Heart rate
|
SpO2
|
Mean arterial pressure (MAP)
|
Arterial blood gases (ABGs)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Robert L Levine, MD, University of Texas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2006
Study Completion
September 1, 2006
Study Registration Dates
First Submitted
January 17, 2006
First Submitted That Met QC Criteria
January 17, 2006
First Posted (Estimate)
January 19, 2006
Study Record Updates
Last Update Posted (Estimate)
November 16, 2006
Last Update Submitted That Met QC Criteria
November 15, 2006
Last Verified
November 1, 2006
More Information
Terms related to this study
Other Study ID Numbers
- CR-0038
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intracranial Pressure
-
Marmara UniversityTerminatedIntraocular Pressure | Intracranial Pressure | Positive End-expiratory PressureTurkey
-
Saint John's Cancer InstituteNational Space Biomedical Research InstituteCompleted
-
Abant Izzet Baysal UniversityUnknown
-
Gloucestershire Hospitals NHS Foundation TrustUnknown
-
Zagazig UniversityCompletedIntracranial Pressure ChangesEgypt
-
Université de SherbrookeUnknownIntracranial Pressure | OsmotherapyCanada
-
Lashmi VenkatraghavanUniversity Health Network, TorontoCompletedElevated Intracranial Pressure (ICP)Canada
-
University Hospital, ToulouseCompletedIncreased Intracranial Pressure DisordersFrance
-
RenJi HospitalUnknownIntracranial Pressure | Neurosurgery | Information ManagementChina
-
HeadSense MedicalUnknownPresence of High Intracranial PressureUnited States, Germany
Clinical Trials on High Frequency Chest Wall Oscillation
-
Royal Brompton & Harefield NHS Foundation TrustCompleted
-
Hui-Ling LinRecruiting
-
University of MinnesotaHill-RomCompletedCystic FibrosisUnited States
-
Hill-RomCompletedCerebral PalsyUnited States
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan
-
Cairo UniversityRecruitingChronic Obstructive Pulmonary DiseaseEgypt
-
Icahn School of Medicine at Mount SinaiInternational Biophysics Corporation; SPARK HealthcareTerminatedCovid19 | Chronic Obstructive Pulmonary Disease | Chronic CoughUnited States
-
The University of Texas Health Science Center at...ALS AssociationCompletedAmyotrophic Lateral Sclerosis | Respiratory Muscle WeaknessUnited States
-
Cairo UniversityNot yet recruiting
-
University of British ColumbiaCanadian Cystic Fibrosis FoundationCompleted